Lv41
500 积分 2024-11-23 加入
Interpretable machine learning analysis of immunoinflammatory biomarkers for predicting CHD among NAFLD patients
3小时前
待确认
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction–associated steatotic liver disease
4天前
求助中
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction–associated steatotic liver disease
4天前
已完结
A 56-Year-0ld Man with Abnormal Results on Liver Testing
1个月前
已完结
Increased risk of hepatocellular carcinoma in HBeAg-negative indeterminate phase compared to HBeAg-negative chronic infection
2个月前
已完结
The association between donor genetic variations in one-carbon metabolism pathway genes and hepatitis B recurrence after liver transplantation
3个月前
已完结
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
4个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
5个月前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
5个月前
已完结
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B
5个月前
已完结
皖公网安备34019202002308
